3 unchanged sentences
Issuer Purchases of Equity Securities
−Removed: The table below sets forth information regarding repurchases of our common stock by us during the three months ended January 1, 2023:
−Removed: Period Total Number of Shares Purchased (1) Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)
+Added: The table below sets forth information regarding repurchases of our common stock by us during the three months ended December 31, 2023:
+Added: Period Total Number of Shares Purchased (1)
+Added: Average Price Paid per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)
October 2, 2023 - October 29, 2023 3,674 $ 66.64 — $ 225,677,460
October 30, 2023 - November 26, 2023 121,783 60.28 120,000 218,444,460
−Removed: November 28, 2022 - January 1, 2023 1,103 89.99 — 225,677,460
+Added: November 27, 2023 - December 31, 2023 858 70.68 — 218,444,460
Total 126,315 $ 60.54 120,000 $ 218,444,460
(1) Includes shares surrendered, if any, to the Company to satisfy the payment of minimum tax withholding obligations.
−Removed: (2) On December 18, 2018, Quidel announced a stock repurchase program to repurchase up to $50.0 million of its common stock, which was authorized by Quidel’s board of directors (the “Quidel Board”) on December 12, 2018.
−Removed: On August 28, 2020, the Quidel Board authorized an increase of an additional $150.0 million to Quidel’s existing stock repurchase program authorization, which was announced on September 1, 2020.
−Removed: The Quidel Board also extended the stock repurchase program through August 28, 2022.
−Removed: In connection with the consummation of the Combinations, Quidel’s $150.0 million stock repurchase program was terminated.
−Removed: On August 17, 2022, the Board authorized a stock repurchase program, allowing the Company to repurchase up to $300.0 million of its common stock through August 17, 2024.
+Added: (2) On August 17, 2022, the Board authorized a stock repurchase program, allowing the Company to repurchase up to $300.0 million of its common stock through August 17, 2024 (the “Stock Repurchase Program”).
+Added: During the three months ended December 31, 2023, the Company repurchased 120,000 shares of outstanding common stock under the Stock Repurchase Program for approximately $7.2 million.
STOCKHOLDER RETURN PERFORMANCE GRAPH
−Removed: Set forth below is a line graph comparing the yearly percentage change in the cumulative total stockholder return on our common stock with the cumulative total returns of the Nasdaq Composite Index and Nasdaq Health Care Index for the five years ended January 1, 2023.
−Removed: The graph assumes (i) an initial investment of $100 as of the market close on December 29, 2017 in our common stock, the Nasdaq Composite Index and the Nasdaq Health Care Index and (ii) reinvestment of dividends.
+Added: Set forth below is a line graph comparing the yearly percentage change in the cumulative total stockholder return on our common stock with the cumulative total returns of the Nasdaq Composite Index and Nasdaq Health Care Composite Index for the five years ended December 31, 2023.
+Added: The graph assumes (i) an initial investment of $100 as of the market close on December 31, 2018 in our common stock, the Nasdaq Composite Index and the Nasdaq Health Care Composite Index and (ii) reinvestment of dividends.
The graph represents stock price performance of Quidel, from fiscal year 2019 through May 27, 2022, and QuidelOrtho following the closing date of the Combinations.
7 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.